NKTX Stock Analysis: Buy, Sell, or Hold?
NKTX - Nkarta, Inc. Common Stock
$2.79
0.00 (-0.18%)
▼
5d:
-17.6%
30d:
+0.91%
90d:
+21.62%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When NKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NKTX is down 17.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NKTX is down 17.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NKTX is currently trading at $2.79, which is considered fair relative to its 30-day fair value range of $2.58 to $3.16.
Technical Outlook: Technically, NKTX is in a strong uptrend. Immediate support is located at $2.32, while resistance sits at $3.34.
Market Sentiment: NKTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.33 (+306.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NKTX is in a strong uptrend. Immediate support is located at $2.32, while resistance sits at $3.34.
Market Sentiment: NKTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.33 (+306.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.58 -
$3.16
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 306.2% below Wall St target ($11.33)
- WARNING: Recommendation downgraded due to -17.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.58 -
$3.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.32
Resistance Level
$3.34
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.69
Wall Street Target
$11.33
(+306.2%)
Share & Embed Analysis
Last updated: July 14, 2026 10:42 AM ET
Data refreshes hourly during market hours. Next update: 11:42 AM
Data refreshes hourly during market hours. Next update: 11:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
